Variant angina associated with a CGRP receptor antagonist: a case report
Abstract Background Calcitonin gene-related peptide (CGRP) plays a pivotal role in migraine pathophysiology, and CGRP receptor antagonists are increasingly used for acute and preventive treatment. While considered to have minimal cardiovascular risk, real-world safety data remain limited, particular...
Saved in:
| Main Authors: | Hongki Jeon, Jin-Man Cho |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-025-04260-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Pharmacokinetics of Atogepant in Healthy Japanese and White Adults
by: Ramesh R. Boinpally, et al.
Published: (2025-01-01) -
Pharmacokinetics of Atogepant in Healthy Lactating Female Participants: Results from a Phase 1 Lactation Study
by: Ramesh R. Boinpally, et al.
Published: (2025-06-01) -
Small-molecule CGRP antagonist atogepant does not affect cortical spreading depression susceptibility in rats
by: Xuyan Jin, et al.
Published: (2025-08-01) -
Expert consensus on gepants for acute and preventive treatment of migraine in Thailand
by: Prakit Anukoolwittaya, et al.
Published: (2025-06-01) -
“The efficacy and safety of Atogepant for migraine prophylaxis: a systematic review and meta-analysis of randomized controlled trials”
by: Ayesha Shaukat, et al.
Published: (2025-08-01)